Affiliation:
1. Postgraduate Course of Infectious Diseases and Tropical Medicine School of Medicine, Universidade Federal de Minas Gerais Belo Horizonte MG Brazil
2. School of Medicine Federal University of Minas Gerais Belo Horizonte MG Brazil
3. Department of Morphology, Institute of Biological Sciences Federal University of Minas Gerais Belo Horizonte MG Brazil
4. Departament of Cardiology Hospital Felício Rocho Belo Horizonte MG Brazil
Abstract
AbstractAimsWe analysed intestinal permeability in patients with chronic Chagas cardiomyopathy (CCC) and evaluated its association with clinical manifestations, haemodynamic parameters measured by echocardiogram, and disease outcome. Intestinal permeability was compared between CCC patients and a group of healthy controls.BackgroundIntestinal dysfunction may contribute to a more severe disease presentation with worse outcome in patients with CCC and heart failure.MethodsFifty patients with CCC and left ventricular ejection fraction (LVEF) of less than 55% were prospectively selected and followed for a mean period of 18 ± 8 months. A group of 27 healthy volunteers were also investigated. One patient was excluded from the analysis since he died before completing the intestinal permeability test.Intestinal permeability was evaluated with the sugar probe drink test. It consists in the urinary recovery of previously ingested sugar probes: mannitol, a monosaccharide, and lactulose, a disaccharide.ResultsPatient's mean age was 53.4 ± 10.4 years, and 31(63%) were male. Differential urinary excretion of lactulose/mannitol ratio did not differ significantly between healthy controls and CCC patients, regardless of clinical signs of venous congestion, haemodynamic parameters, and severity of presentation and outcome.ConclusionsThe present study could not show a disturbance of the intestinal barrier in CCC patients with LVEF <55%, measured by lactulose/mannitol urinary excretion ratio. Further investigations are needed to verify if in patients with LVEF <40% intestinal permeability is increased.
Funder
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Subject
Cardiology and Cardiovascular Medicine
Reference24 articles.
1. Chagas disease in Latin America: an epidemiological update based on 2010 estimates = Maladie de Chagas en Amérique latine: le point épidémiologique basé sur les estimations de 2010;World Health Organization;Wkly Epidemiol Rec,2015
2. Chagas Cardiomyopathy
3. Predictors of Mortality in Chronic Chagas Disease
4. Mortality prediction in Chagas heart disease
5. A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy